Details for Patent: 10,376,496
✉ Email this page to a colleague
Which drugs does patent 10,376,496 protect, and when does it expire?
Patent 10,376,496 protects ZERBAXA and is included in one NDA.
This patent has seven patent family members in four countries.
Summary for Patent: 10,376,496
| Title: | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| Abstract: | Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection. |
| Inventor(s): | Krishna; Gopal (Stow, MA), Chandorkar; Gurudatt (Waltham, MA), Hershberger; Elham (Lexington, MA), Miller; Benjamin (Cambridge, MA), Xiao; Alan (Lexington, MA) |
| Assignee: | Merck, Sharp & Dohme Corp. (Rahway, NJ) |
| Application Number: | 14/481,496 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,376,496
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF COMPLICATED URINARY TRACT INFECTION IN PATIENTS WITH END-STAGE RENAL DISEASE ON HEMODIALYSIS | ⤷ Sign Up | ||||
| Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTION IN PATIENTS WITH END-STAGE RENAL DISEASE ON HEMODIALYSIS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,376,496
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014233637 | ⤷ Sign Up | |||
| Australia | 2016202199 | ⤷ Sign Up | |||
| Australia | 2017279686 | ⤷ Sign Up | |||
| Australia | 2020202756 | ⤷ Sign Up | |||
| European Patent Office | 3043797 | ⤷ Sign Up | |||
| Spain | 2800603 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2015035376 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
